SEC Form 4 · accession 0001218105-15-000001
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William R Shanahan Jr.
Officer — SVP & Chief Medical Officer
Period of report
Jan 7, 2015
Accepted (ET)
Jan 8, 2015 · 9:07 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 7, 2015 | M | 50,000 | $1.49 | A | 100,000 | D | |
| Common Stock | Jan 7, 2015 | S | 50,000 | $5.49 | D | 50,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F2 | $1.49 | Jan 7, 2015 | M | 50,000 | D | — | Mar 15, 2021 | Common Stock | 50,000 | 150,000 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The options vest in four equal annual installments, and are exercisable once vested. The first, second and third installments became exercisable on March 15, 2012, 2013 and 2014, respectively, and the fourth installment vests on March 15, 2015.